Genfit S.A. (EPA:GNFT)
13.32
-0.18 (-1.33%)
Jul 14, 2026, 9:13 AM CET
Genfit Revenue
In the year 2025, Genfit had annual revenue of 70.85M EUR with 0.22% growth. Genfit had revenue of 35.31M in the half year ending December 31, 2025, with 82.28% growth.
Revenue
70.85M
Revenue Growth
+0.22%
P/S Ratio
9.53
Revenue / Employee
440.03K
Employees
161
Market Cap
675.33M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 70.85M | 153.00K | 0.22% |
| Dec 31, 2024 | 70.69M | 36.21M | 105.01% |
| Dec 31, 2023 | 34.48M | 8.24M | 31.38% |
| Dec 31, 2022 | 26.25M | -59.11M | -69.25% |
| Dec 31, 2021 | 85.36M | 76.67M | 883.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Valneva SE | 156.33M |
| Cellectis | 65.14M |
| Nanobiotix | 32.59M |
| MedinCell | 24.28M |
| Innate Pharma | 9.01M |
| Transgene | 7.21M |
| Inventiva | 6.76M |
| Sensorion | 5.81M |
Genfit News
- 20 days ago - GENFIT: Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with Cholangiocarcinoma - GlobeNewsWire
- 4 weeks ago - GENFIT: June 15, 2026 Combined Shareholders Meeting Results - GlobeNewsWire
- 5 weeks ago - GENFIT: NASHnext®, Powered by GENFIT's Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp's OnDemand Offering for Identification of At-Risk MASH - GlobeNewsWire
- 7 weeks ago - Genfit Earnings release: Q1 2026 - Filings
- 2 months ago - Genfit Slides: Investor presentation - Filings
- 3 months ago - Genfit Annual report: Q4 2025 - Filings
- 3 months ago - Genfit Earnings release: Q4 2025 - Filings
- 4 months ago - Genfit Earnings release: Q4 2025 - Filings